Subsequent Primary Cancers in Ovarian Cancer Patients
Author Information
Author(s): P. Prior, D.J. Pope
Primary Institution: Cancer Epidemiology Research Unit, Department of Social Medicine, University of Birmingham
Hypothesis
Does treatment for ovarian cancer increase the risk of subsequent primary cancers?
Conclusion
Patients treated for ovarian cancer have a significantly higher risk of developing subsequent primary cancers, particularly acute and non-lymphocytic leukaemia.
Supporting Evidence
- 213 subsequent cancers were observed in the cohort, significantly higher than the expected 140.
- The relative risk of acute and non-lymphocytic leukaemia was found to be 27.8 among those treated with chemotherapy.
- Significant excesses of subsequent cancers were observed at several sites including breast, lung, and nervous system.
Takeaway
Women who have had treatment for ovarian cancer might get other types of cancer later on, especially leukaemia.
Methodology
The study analyzed data from 7,203 ovarian cancer patients to assess the incidence of subsequent primary cancers based on treatment received.
Potential Biases
Potential bias due to incomplete reporting of treatments and the exclusion of certain cases from analysis.
Limitations
The study relied on routinely collected registry data, which may have inaccuracies.
Participant Demographics
Patients diagnosed with ovarian cancer between 1957 and 1976, with a follow-up until 1982.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI 1.3-1.7
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website